WASHINGTON, D.C. — The U.S. Food and Drug Administration announced Tuesday that it is taking steps to remove pediatric ingestible fluoride prescription products from the market. The FDA cited ...

Semaglutide injections are helping you lose weight-but if yours isn't FDA-approved (and a lot of them aren't), it could be ...

On September 27, 2024, in USA v. California Stem Cell Treatment Center, Inc., the US Court of Appeals for the Ninth Circuit issued a decision agreeing with the US Food and Drug Administration (FDA ...

The FDA warned, however, that the marketing authorization does not mean that the products are safe or "FDA approved." "There is no safe tobacco product; youth should not use tobacco products and ...

The Food and Drug Administration (FDA) announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

Post-market safety monitoring: Even after approval, the FDA continues to track its performance and potential side effects. This process can stretch over a decade.

Additionally, this action is not an authorization or indication of appropriateness to market these products as modified risk tobacco products." To date, FDA has authorized 34 e-cigarette products ...

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was ...